You are here

DAPA-CKD trial

Thursday, 24 September 2020, 17:15 - 18:15, Klagenfurt Hall

Chair: S.M. Marshall, UK

P. Rossing, DK: Background and rationale of the DAPA-CKD trial

D.C. Wheeler, UK: Design and patient population

H.J.L. Heerspink, NL: Results of the DAPA-CKD trial

C. Mathieu, BE: Commentary